Wednesday , 4 December 2024
Home Drug Withdrawal

Drug Withdrawal

Amylyx Pharmaceuticals
Healthcare

ALS Drug Relyvrio Withdrawn Due to Ineffectiveness

Amylyx Pharmaceuticals has decided to withdraw its ALS drug Relyvrio from the market following disappointing results from a phase III trial. The drug,...